Înapoi

Selectați regiunea dumneavoastră

Corporate

Europa:

Steagul Albania Albania Steagul Bosnia-Herțegovina Bosnia-Herțegovina Steagul Bulgaria Bulgaria Steagul Cipru Cipru Steagul Croația Croația Steagul Cehia Cehia Steagul Danemarca Danemarca Steagul Elveția Elveția Steagul Estonia Estonia Steagul Germania Germania Steagul Italia Italia Steagul Kosovo Kosovo Steagul Letonia Letonia Steagul Lituania Lituania Steagul Luxemburg Luxemburg Steagul Marea Britanie Marea Britanie Steagul Macedonia Macedonia Steagul Muntenegru Muntenegru Steagul Polonia Polonia Steagul Portugalia Portugalia Steagul România România Steagul Serbia Serbia Steagul Slovacia Slovacia Steagul Slovenia Slovenia Steagul Spania Spania Steagul Suedia Suedia Steagul Turcia Turcia Steagul Ungaria Ungaria

Asia:

Steagul Hong Kong Hong Kong Steagul Kuwait Kuwait Steagul Liban Liban Steagul UAE UAE

Africa:

Steagul Africa de Sud Africa de Sud

Contactează-ne și obține oferta!

Află mai multe acum!

Contactați-ne astăzi!

Doriți să aflați mai multe despre serviciile noastre? Completați formularul de mai jos și vă vom contacta în cel mai scurt timp posibil pentru a vă oferi toate informațiile de care aveți nevoie și pentru a vă răspunde la întrebări.

    Vă rugăm să fiți informat că datele personale furnizate în formular vor fi prelucrate de Biogenis - banca de celule stem cu sediul social în București, Bd. Dimitrie Pompei, Nr. 10A, Cladirea Conect 1, Sector 2 pentru a va contacta telefonic/e-mail în legătură cu furnizarea de informații despre serviciile deținute.

    Imagine

    Exemple
    de utilizări

    Terapiile cu celule stem

    În cadrul Grupului FamiCord sunt stocate peste 1.000.000 de probe biologice, care au ajutat la tratamentului a peste 8000 de pacienti din mai mult de 30 de țări, iar prin intermediul Biogenis peste 200 de pacienti au beneficiat de tratament.

    Grupul FamiCord deține 2 laboratoare ce întrunesc standardele GMP, solicitate de Agenția Europeană a Medicamentului (EMA), pentru a furniza ATMP (tratament personalizat pe bază de celule stem mezenchimale) atunci când este necesar.

    Tabelul pacienților 06.2026

    Imagine
    Tabelul pacienților 06.2026
    Nr. Sursa Tipul sursei Diagnostic Aria medicala Anul utilizarii Terapie Tara Varsta pacient
    4401 Apheresis Autologous Bone Tumor Hematology 2020 Standard Therapy Germany 28
    4402 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2020 Standard Therapy Poland 49
    4403 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2020 Standard Therapy Poland 74
    4404 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2020 Standard Therapy Poland 67
    4405 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2020 Standard Therapy Poland 58
    4406 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2020 Standard Therapy Poland 61
    4407 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2020 Standard Therapy Poland 56
    4408 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2020 Standard Therapy Poland 47
    4409 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2020 Standard Therapy Poland 73
    4410 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2020 Standard Therapy Poland 62
    4411 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2020 Standard Therapy Poland 57
    4412 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2020 Standard Therapy Poland 44
    4413 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2020 Standard Therapy Poland 62
    4414 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2020 Standard Therapy Poland 66
    4415 Apheresis Allogeneic Chronic Neutrophilic Leukemia Hematology 2020 Standard Therapy Germany 31
    4416 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2020 Standard Therapy Poland 63
    4417 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2020 Standard Therapy Germany 68
    4418 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2020 Standard Therapy Germany 51
    4419 Apheresis Allogeneic Dyskeratosis Congenita Hematology 2020 Standard Therapy Poland 19
    4420 Apheresis Allogeneic Erdheim-Chester Disease Hematology 2020 Standard Therapy Poland 4
    4421 Apheresis Autologous Ewing Sarcoma Hematology 2020 Standard Therapy Germany 30
    4422 Apheresis Allogeneic Fanconi Anemia Hematology 2020 Standard Therapy Poland 1
    4423 Apheresis Allogeneic Fanconi Anemia Hematology 2020 Standard Therapy Poland 29
    4424 Apheresis Autologous Germ Cell Tumor Hematology 2020 Standard Therapy Germany 30
    4425 Apheresis Autologous Hodgkin Lymphoma Hematology 2020 Standard Therapy Germany 48
    4426 Apheresis Autologous Hodgkin Lymphoma Hematology 2020 Standard Therapy Germany 22
    4427 Apheresis Autologous Hodgkin Lymphoma-Relapse Hematology 2020 Standard Therapy Germany 66
    4428 Apheresis Allogeneic Lymphoblastic Lymphoma Hematology 2020 Standard Therapy Poland 24
    4429 Apheresis Allogeneic Mantle Cell Lymphoma Hematology 2020 Standard Therapy Poland 56
    4430 Apheresis Autologous Mantle Cell Lymphoma Hematology 2020 Standard Therapy Germany 56
    4431 Apheresis Autologous Mantle Cell Lymphoma Hematology 2020 Standard Therapy Germany 48
    4432 Apheresis Autologous Mantle Cell Lymphoma Hematology 2020 Standard Therapy Germany 53
    4433 Apheresis Autologous Mantle Cell Lymphoma Hematology 2020 Standard Therapy Germany 59
    4434 Apheresis Autologous Mantle Cell Lymphoma Hematology 2020 Standard Therapy Germany 65
    4435 Apheresis Autologous Mantle Cell Lymphoma Hematology 2020 Standard Therapy Germany 58
    4436 Apheresis Autologous Mantle Cell Lymphoma Hematology 2020 Standard Therapy Germany 49
    4437 Apheresis Allogeneic Mast Cell Leukemia Hematology 2020 Standard Therapy Germany 55
    4438 Apheresis Autologous Morbus Hodgkin Hematology 2020 Standard Therapy Germany 68
    4439 Apheresis Autologous Morbus Hodgkin Hematology 2020 Standard Therapy Germany 53
    4440 Apheresis Autologous Morbus Hodgkin-Relapse Hematology 2020 Standard Therapy Germany 18
    4441 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 54
    4442 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 66
    4443 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 56
    4444 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 65
    4445 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 70
    4446 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 41
    4447 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 56
    4448 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 61
    4449 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 55
    4450 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 67
    4451 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 52
    4452 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 69
    4453 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 64
    4454 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 46
    4455 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 55
    4456 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 60
    4457 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 65
    4458 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 51
    4459 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 55
    4460 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 63
    4461 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 65
    4462 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 55
    4463 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 65
    4464 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 68
    4465 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 65
    4466 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 42
    4467 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 59
    4468 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 66
    4469 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 65
    4470 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 67
    4471 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 65
    4472 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 60
    4473 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 68
    4474 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 63
    4475 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 68
    4476 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 63
    4477 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 62
    4478 Apheresis Allogeneic Multiple Myeloma Hematology 2020 Standard Therapy Germany 49
    4479 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 45
    4480 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 65
    4481 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 45
    4482 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 66
    4483 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 40
    4484 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 53
    4485 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 54
    4486 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 44
    4487 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 68
    4488 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 48
    4489 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 68
    4490 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 66
    4491 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 68
    4492 Apheresis Autologous Multiple Myeloma Hematology 2020 Standard Therapy Germany 54
    4493 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 67
    4494 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 59
    4495 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 60
    4496 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 62
    4497 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 55
    4498 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 70
    4499 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 66
    4500 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 51